Celcuity (CELC) Return on Equity [ROE] (2017 - 2026)
Celcuity (CELC) reported Return on Equity [ROE] of -498.80% for Q2 2026, down 271.84 percentage points from -226.96% a year earlier.
Powered by 
Analysis
Celcuity (CELC) Return on Equity [ROE] (2017 - 2026) Analysis & Trends
For FY2025, Celcuity posted Return on Equity [ROE] of -163.80%, down 76.26 percentage points from FY2024.
- Return on Equity [ROE] has declined for three consecutive years, with a five-year change of -102.67 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -87.54% in FY2024 (-40.90 pp), -46.63% in FY2023 (-6.76 pp), -39.88% in FY2022 (+33.76 pp) and -73.63% in FY2021 (-12.51 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] in data going back to Q4 2017.
- The high point for year-over-year Return on Equity [ROE] in five years was Q4 2021 (a gain of 33.06 percentage points); the low point was Q2 2026 (a drop of 271.84 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Celcuity | 3.29 Bn | 2.65 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,111.73% |
| Mar 31, 2026 | -250.37% |
| Dec 31, 2025 | -162.78% |
| Sep 30, 2025 | -201.72% |
| Jun 30, 2025 | -226.96% |
| Mar 31, 2025 | -125.73% |
| Dec 31, 2024 | -84.26% |
| Sep 30, 2024 | -57.58% |
| Jun 30, 2024 | -53.21% |
| Mar 31, 2024 | -53.71% |
| Dec 31, 2023 | -54.82% |
| Sep 30, 2023 | -55.67% |
| Jun 30, 2023 | -42.00% |
| Mar 31, 2023 | -34.53% |
| Dec 31, 2022 | -45.54% |
| Sep 30, 2022 | -73.50% |
| Jun 30, 2022 | -53.48% |
| Mar 31, 2022 | -53.36% |
| Dec 31, 2021 | -41.35% |
| Sep 30, 2021 | -50.05% |
API Access
Celcuity Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CELC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CELC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CELC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();